Page 540 - Si Reporter

Sensex up 1,277 pts, ends above 58K; Nifty tops 17,250; banks, metals lead

CLOSING BELL: IndusInd Bank, Bajaj Finance, TCS, HDFC, Bajaj Finserv, Tata Steel, HDFC Bank, Wipro, L&T, Axis Bank, ITC, SBI, and Infosys were the top Sensex gainers

Liberty Shoes hits multi-yr high on strong outlook; stock up 104% in 1-mnth

Going ahead, the company aims to grow by 30 per cent in the year 2022-23 and is confident enough to achieve the highest ever top line and Profit before tax (PBT) in the year 2022-23

Sensex down 638 pts; Nifty nears 16900; Adani Group stocks slide, pharma up

CLOSING BELL: Adani Enterprises was the biggest Nifty dragger as it dropped 9 per cent

Eicher Motors down 9% from day's high on profit booking; analysts bullish

Royal Enfield volume prints for the month September came in stellar, and were at a multi-year high in the recent past

Adani Group stocks crack; Adani Enterprises, ATGL hit 10% lower limit

Adani Enterprises and Adani Total Gas were the major losers among the group stocks, as they hit the 10 per cent lower circuit in intraday deals.

Adani Enterprises slips for seventh day, falls 5%; stock tanks 9% in 1 week

The stock was down 5% to Rs 3,280 on the NSE in the intra-day trade today, falling 16% from its record high level of Rs 3,885

Nifty Pharma outshines benchmarks, up 2%; Cipla, Sun Pharma hit 52-wk highs

Shares of Glenmark Pharma, Granules India, Divi's Laboratories, Torrent Pharma, Lupin and Aurobindo Pharma, surged in the range of 2 per cent to 6 per cent in Monday's intra-day trade

Nykaa soars 11% after board approves 5:1 bonus share

The company has fixed November 03, 2022, as the record date for the purpose of determining shareholders eligible for bonus equity shares.

RITES hits all-time high on healthy outlook; stock climbs 15% in 3 days

The stock of state-owned engineering, designing & construction company traded higher for the third straight day, surging 15 per cent, during the period

Chalet Hotels up 6%, hits 52-week high in a weak market on ratings upgrade

The Positive Outlook reflects a consistent recovery in CHL's business operations since 2QFY22, with 1QFY23 revenue and EBITDA exceeding the pre-COVID-19 levels.

ONGC, Oil India gain up to 6% as govt increases gas prices; MGL falls 4%

The government has hiked prices of domestically produced natural gas for the October 2022-March 2023 period

Sensex jumps 1,017 pts on RBI's 50-bps hike; Nifty nears 17,100; banks lead

CLOSING BELL: The benchmark indices snapped their seven-day losing streak as the RBI delivered a 50-basis point repo rate hike, and underscored the resilience of the Indian economy in his statement

Bharti Airtel hits record high ahead of 5G services launch; stock soars 6%

Analysts at JPMorgan believe that Bharti Airtel is one of the key beneficiaries of Indian wireless market consolidation.

Adani Green Energy up 20% on heavy volume; exchange data shows block deal

In September, Spitze Trade and Investment Limited, one of the promoters of AGEL acquired 4 million equity shares representing 0.25 per cent of total equity of the company via open market deals.

More rate hikes, eye on rupee: How experts interpret RBI's 50-bps rate hike

The reluctance of the RBI to change stance from 'withdrawal of accommodation' indicates that more monetary policy tightening is likely to be in the pipeline, analysts said

Gujarat Flurochem hits new high on healthy outlook; zooms 109% in 1 year

Adoption of 5G-enabled smartphones in India is expected to triple and this, in turn, will drive the fluoropolymers market and benefit the Gujarat Fluorochemicals.

Aurionpro soars to 14-year high; stock up 83% in the last 3 months

The stock hit an intra-day high of Rs 468, and has surged 14% in the last two trading sessions.

Reliance Industries' stock hits over 6-month low; slips 7% in one week

Thus far in the month of September, RIL's stock has shed 12 per cent, as compared to 2.7 per cent decline in the Sensex

Sun Pharma extends rally, surges 7% in two days; now trades at 5-month high

Sun Pharma could see structural growth and be relatively insulated from the adverse price erosion scenario in the US, according to analysts.

Lupin dips 3% as US FDA issues warning letter for Tarapur facility

Lupin said it does not believe the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility